Tinnitus is a condition when a person hears a ringing sound or a different variety of sounds when no corresponding external sound is present and that other people cannot hear.
Tinnitus is usually associated with hearing loss and decreased comprehension of speech in noisy environments. It is common, affecting about 10–15% of people. Most tolerate it well, and it is a significant (severe) problem in only 1–2% of people.
Rather than a disease, tinnitus is a symptom that may result from a variety of underlying causes and may be generated at any level of the auditory system as well as outside that system. The most common causes are hearing damage, noise-induced hearing loss, or age-related hearing loss, known as presbycusis. Other causes include , disease of the heart or blood vessels, Ménière's disease, , acoustic neuromas (tumors on the auditory nerves of the ear), migraines, temporomandibular joint disorders, exposure to certain medications, a previous head injury, and earwax. In some people, it interferes with concentration, and can be associated with anxiety and depression. It can suddenly emerge or increase during a period of emotional stress. It may have a frequent occurrence in those with depression.
The diagnosis of tinnitus is usually based on a patient's description of the symptoms they are experiencing. Such a diagnosis is commonly supported by an audiogram, and an otolaryngological and neurological examination. How much tinnitus interferes with a person's life may be quantified with questionnaires. If certain problems are found, medical imaging, such as magnetic resonance imaging (MRI), may be performed. Other tests are suitable when tinnitus occurs with the same rhythm as the heartbeat. Rarely, the sound may be heard by someone other than the patient by using a stethoscope, in which case it is known as "objective tinnitus". Occasionally, spontaneous otoacoustic emissions, sounds produced normally by the inner ear, may result in tinnitus.
Measures to prevent tinnitus include avoiding chronic or extended exposure to loud noise, and limiting exposure to drugs and substances harmful to the ear (ototoxicity). If there is an underlying cause, treating that cause may lead to improvements. Otherwise, typically, tinnitus management involves psychoeducation or counseling, such as talk therapy. Tinnitus masker or hearing aids may help. No medication directly targets tinnitus.
Psychological research has focused on the tinnitus distress reaction to account for differences in tinnitus severity. The research indicates that among the cohort studied, conditioning at the initial perception of tinnitus linked it with negative emotions, such as fear and anxiety.
In rare cases, tinnitus may be heard by someone else using a stethoscope. Even more rarely, in some cases it may be measured as a spontaneous otoacoustic emission (SOAE) in the ear canal. This is classified as "objective tinnitus", also called "pseudo-tinnitus" or "vibratory" tinnitus.
When there does not seem to be a connection with a disorder of the inner ear or auditory nerve, tinnitus may be called "non-otic". In 30% of cases, tinnitus is influenced by the somatosensory system; for instance, people can increase or decrease their tinnitus by moving their face, head, jaw, or neck. This type is called somatic or craniocervical tinnitus, since it is only head or neck movements that have the effect.
Some tinnitus may be caused by neuroplastic changes in the central auditory pathway. In this theory, the disturbance of sensory input caused by hearing loss results in such changes, as a homeostatic response of neurons in the central auditory system, causing tinnitus.
When some frequencies of sound are lost to hearing loss, the auditory system compensates by amplifying those frequencies, eventually producing sound sensations at those frequencies constantly, even when there is no corresponding external sound.
In many cases, no underlying cause is identified.
Ototoxicity drugs also may cause subjective tinnitus, as they may cause hearing loss, or increase the damage done by exposure to loud noise. This damage may occur even at doses not considered ototoxic.
Tinnitus may also occur from the discontinuation of therapeutic doses of . It may sometimes be a protracted symptom of benzodiazepine withdrawal and may persist for many months. Medications such as bupropion may also cause tinnitus.
Spontaneous otoacoustic emissions (SOAEs)—faint high-frequency tones that are produced in the inner ear and may be measured in the ear canal with a sensitive microphone—may also cause tinnitus. About 8% of those with SOAEs and tinnitus have SOAE-linked tinnitus, while the percentage of all cases of tinnitus caused by SOAEs is estimated at 4%.
The differential diagnosis for pulsatile tinnitus is wide and includes vascular etiologies, tumors, disorders of the middle ear or inner ear, and other intracranial pathologies. Vascular causes of pulsatile tinnitus include venous causes (e.g., high riding or dehiscent jugular bulb, sigmoid sinus diverticulum), arterial causes (e.g., cervical atherosclerosis, potentially life-threatening conditions such as carotid artery aneurysm or carotid artery dissection), or dural arteriovenous fistula or arteriovenous malformations.
Pulsatile tinnitus may also indicate vasculitis, or more specifically, giant cell arteritis. Pulsatile tinnitus may also be caused by tumors such as (e.g., glomus tympanicum, glomus jugulare), or (e.g., facial nerve or cavernous). Middle ear causes of pulsatile tinnitus include patulous eustachian tube, otosclerosis, or middle ear myoclonus (e.g., Stapedius muscle or tensor tympani myoclonus). The most common inner ear cause of pulsatile tinnitus is superior semicircular canal dehiscence. Pulsatile tinnitus may also indicate idiopathic intracranial hypertension. Pulsatile tinnitus may be a symptom of intracranial vascular abnormalities and should be evaluated for irregular noises of blood flow ().
Tinnitus may cause stress by triggering a fight-or-flight response in brain chemistry, as the brain may perceive it as dangerous and important, and in 2021 was documented as reported by study subjects as increasing during otherwise stressful situations.
Three reviews in 2016 emphasized the large range and possible combinations of pathologies involved in tinnitus, which result in a great variety of symptoms and specifically adapted therapies.
Evaluation of tinnitus may include a hearing test (audiogram), measurement of acoustic parameters of the tinnitus such as pitch and loudness, and psychological assessment of comorbid conditions such as depression, anxiety, and stress that might be associated with severity of the tinnitus.
One definition of tinnitus, in contrast to normal ear noise experience, is that tinnitus lasts five minutes at least twice a week. However, people with tinnitus often experience the noise more frequently than this. Tinnitus may be present constantly or intermittently. Some people with constant tinnitus might not be aware of it all the time, but only, for example, during the night or in situations when there is less environmental noise to mask it. Chronic tinnitus may be defined as tinnitus with a duration of six months or more.
Another relevant parameter of tinnitus is residual inhibition: the temporary suppression or disappearance of tinnitus following a period of masking. The degree of residual inhibition may indicate how effective tinnitus maskers would be as treatment.
Hyperacusis is related to negative reactions to sound and may take many forms. One parameter that may be measured is Loudness Discomfort Level (LDL) in dB, which is the subjective level of acute discomfort at specified frequencies over the frequency range of hearing. This defines a dynamic range between the hearing threshold at that frequency and the loudness discomfort level. A compressed dynamic range over a particular frequency range may be associated with hyperacusis. The normal hearing comfort threshold is generally defined as 0–20 decibels (dB). Normal loudness discomfort levels are 85–90+ dB, with some authorities citing 100 dB. A dynamic range of 55 dB or lower is indicative of hyperacusis.
Assessment of psychological processes related to tinnitus involves measurement of tinnitus severity and distress, as measured subjectively by validated self-report tinnitus questionnaires. Such questionnaires measure the degree of psychological distress and handicap associated with tinnitus, including effects on hearing, lifestyle, health, and emotional functioning.
Current assessment measures aim to identify levels of distress and interference, coping responses, and perceptions of tinnitus to inform treatment and monitor progress. However, wide variability, inconsistencies, and lack of consensus regarding assessment methodology are evidenced in the literature, limiting comparison of treatment effectiveness. Questionnaires developed to guide diagnosis or classify severity of tinnitus may be treatment-sensitive outcome measures.
Certain groups are advised to wear ear plugs to avoid the risk of tinnitus, such as that caused by overexposure to loud noises such as wind noise for motorcycle riders. This includes military personnel, musicians, DJs, agricultural workers, and construction workers as people in those occupations are at a greater risk compared to the general population.
Several medicines have ototoxic effects, which can have a cumulative effect that increases the damage resulting from loud noise. If ototoxic medications must be administered, close attention by the physician to prescription details, such as dose and dosage interval, may reduce the amount of damage.
There is some tentative evidence supporting tinnitus retraining therapy, which aims to reduce tinnitus-related neuronal activity. An alternative tinnitus treatment uses mobile applications that include various methods including Tinnitus masking, sound therapy, and relaxation exercises. Such applications can work as a separate device or as a hearing aid control system.
Neuromonics is another sound-based intervention. Its protocol follows the principle of systematic desensitization and involves a structured rehabilitation program lasting 12 months. Neuromonics therapy employs customized sound signals delivered through a device worn by the patient, which aims to target the specific frequency range associated with their tinnitus perception.
Botulinum toxin injection has succeeded in some of the rare cases of objective tinnitus resulting from a palatal tremor.
In 2009, use in a few countries of caroverine to treat tinnitus was published.
The Lenire bimodal neuromodulation device marketed by Neuromod was approved as a treatment option for tinnitus in March 2023 by the United States Food and Drug Administration (FDA). In June 2024, the United States Department of Veterans Affairs (VA) announced it would begin offering the treatment to veterans with tinnitus, making it the first bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) contract from the U.S. Government.
Some evidence supports neuromodulation techniques such as transcranial magnetic stimulation, transcranial direct current stimulation, and neurofeedback.
Its reported prevalence varies from 12 to 36% in children with normal hearing thresholds, and up to 66% in children with a hearing loss. Approximately 3–10% of children have been reported to be troubled by tinnitus.
Signs and symptoms
Course
Adverse psychological effects
Types
Subjective tinnitus
Hearing loss
Associated factors
Objective tinnitus
Pediatric tinnitus
Pulsatile tinnitus
Pathophysiology
Diagnosis
Audiology
Psychoacoustics
Hyperacusis
Severity
Pulsatile tinnitus
Differential diagnosis
Prevention
Management
Psychological
Sound-based interventions
Physical therapy
Medications
there were no medications effective for idiopathic tinnitus. There is not enough evidence to determine whether [[antidepressant]]s or [[acamprosate]] are useful to treat tinnitus. There are conflicting studies regarding the effectiveness of [[benzodiazepines]] for tinnitus. As of 2015, the usefulness of [[melatonin]] is unclear. It is unclear whether [[anticonvulsant]]s are useful for treating tinnitus. Steroid injections into the middle ear also do not seem to be effective. There is no evidence to suggest that the use of [[betahistine]] to treat tinnitus is effective.
Neuromodulation
Nerve damage repair via neurotrophins
/ref> Stéphane Maison, an auditory physiologist at Massachusetts Eye and Ear Infirmary, noted in 2023, "Our work reconciles the idea that tinnitus may be triggered by a loss of auditory nerve, including in people with normal hearing... We won't be able to cure tinnitus until we fully understand the mechanisms underlying its genesis. This work is a first step toward our ultimate goal of silencing tinnitus". The study follows studies that established that treatment with neurotrophins demonstrated encouragement for repair of the nerve in other mammals and the findings should lead to investigation of the potential for a treatment for tinnitus in humans.Cockerill, Jess, Tinnitus Could Be Our Brain's Way of Coping With Nerve Damage, Science Alert, December 5, 2023
Alternative medicines not effective
Prognosis
Epidemiology
Adults
Children
See also
Further reading
External links
|
|